The role of EAT has been studied in patients affected by diabetes, confirming that it seems to be associated with obesity, fasting blood glucose levels, insulin resistance, and adiponectin levels in patients with type 2 diabetes mellitus (T2DM), and its increase was observed in patients with type 2 or 1 diabetes [28]. Here, ADIPOQ is linked to obesity disorder.